Company Revenue

The company grew in the mid-teens for the first half of 2023, driven by strength across its trauma portfolio and...

In the second quarter of 2023, the company took steps to stabilize its financial position and assess its strategic path...

The company's orthopedic sales grew in the mid-teens for the second quarter of 2023 on the strength of favorable order...

The company's MACI sales grew 27% in the second quarter of 2023 while both surgeon and biopsy trends point to...

The company notched its fifth consecutive quarter of record revenues in 2Q23, with growth over 30% due to increased demand...

The company grew 40% in the second quarter of 2023 due to its sole focus on bunion surgery and its...

The company grew in the mid-teens for the second quarter of 2023 and raised full-year guidance despite tougher comps in...

The company grew in the mid-single-digits on a pro forma basis for the second quarter of 2023 as it embarks...

The company grew in the double-digits for the second quarter of 2023 as it hit records for both total sales...

The company grew in the mid-single digits for 2Q23 as improving operational execution allowed it to leverage elevated orthopedic volumes....